AAIC25: Cognito neuromodulation therapy slows decline in Alzheimer’s disease
Cognito Therapeutics has presented new data demonstrating its Spectris neuromodulation device’s potential to slow cognitive decline and preserve white matter…
Cognito Therapeutics has presented new data demonstrating its Spectris neuromodulation device’s potential to slow cognitive decline and preserve white matter…
Tivic Health has completed enrolment in a study being conducted to finetune its non-invasive vagus nerve stimulation (VNS) device that…
A Phase II clinical trial evaluating Sinaptica Therapeutics’ neuromodulation device in Alzheimer’s disease has hit its primary and key secondary…
Nexalin Technology has partnered with the University of California, San Diego, to start a clinical trial evaluating the company’s neurostimulation…
Nexalin has unveiled mixed results from a clinical trial evaluating its deep intracranial frequency stimulation (DIFS) technology in patients with…
A new type of self-adjusting neuromodulation is poised to transform the landscape of neurology, as per analyst reaction to results…
SetPoint Medical has been given an investigational device exemption (IDE) from the US Food and Drug Administration (FDA) greenlighting it…
Synchron has cemented its position as the frontrunner in brain computer interface (BCI) clinical trials, after the company reported positive…
New York-based home sleep diagnostics company Wesper has released findings from a case study on hypoglossal nerve stimulation (HGNS) for…
Synergia Medical has successfully implanted the first two patients in a study evaluating its neurostimulation technology for the treatment of…